NMS · Medical - Care Facilities
PNTG (PNTG) Stock
$40.32
-1.97%
NMS: PNTG
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
3 Reasons to Sell PNTG and 1 Stock to Buy Instead
StockStory · Jul 17, 2026
What This Pennant Group Insider Sale Means as Home Health Revenue Surged 43%
Motley Fool · Jul 14, 2026
Truist Raises Price Target on Pennant Group to $48 From $42, Keeps Buy Rating
MT Newswires · Jul 14, 2026
Jim Cramer Outlines Why Pennant Group Stock Can Sail to $55
Insider Monkey · Jul 13, 2026
1 Momentum Stock with Competitive Advantages and 2 We Turn Down
StockStory · Jul 6, 2026
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About PNTG
PNTG is led by CEO Brent J. Guerisoli, employs 7,000 people, headquartered in US, publicly traded since 2019.
PNTG stock trades at $40.32 with a market capitalization of $1.40B. The stock is valued at a price-to-earnings (P/E) ratio of 41.87, price-to-book of 3.67, price-to-sales of 1.20. Over the past 52 weeks the stock has ranged between $21.73 and $41.86, and currently trades 3.7% below its 52-week high.
On profitability, PNTG generates a return on equity (ROE) of 9.01%, return on capital employed of 13.64%, an operating margin of 5.38%, a net profit margin of 2.96%.